Vol.
27
No.
46
December 14, 2001Dec 14, 2001
Free

Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.

AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.

Campus-Dweller Rabson Finds Comfort In NIH Security.

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

Siemens To Provide Technology To DxTx For Lung Cancer Detection.

Myriad In Partnership To Market Products.

Computer-Aided Detection Approved For Mammograms.

Login